Press release
Global High Flow Oxygen Therapy Devices Market to Grow at a Steady Pace Through 2032, Driven by Rising Respiratory Disorders and ICU Admissions | DelveInsight
Global High Flow Oxygen Therapy Devices Market
High-flow oxygen Therapy devices deliver warmed and humidified oxygen at high flow rates, offering better tolerance and improved oxygenation compared to traditional oxygen therapy. These systems, comprising air-oxygen blenders, active humidifiers, single-heated circuits, and nasal cannulas, are being increasingly adopted across emergency departments, intensive care units (ICUs), and post-operative care due to their clinical benefits in managing respiratory distress and avoiding intubation.
Technological advancements in HFOT devices, including integration with portable units, smart monitoring capabilities, and precision flow control, are improving therapeutic outcomes and enhancing patient comfort. In addition, the expansion of home-based respiratory care and telehealth models is further driving the adoption of compact and user-friendly high-flow devices.
DelveInsight's High Flow Oxygen Therapy Devices Market Insights, Competitive Landscape, and Market Forecast - 2032 provides an in-depth analysis of market trends, therapeutic applications, device innovation, and regulatory developments across major geographies such as the United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, Japan, and others. The report evaluates segmentation by application (acute respiratory failure, bronchiolitis, COPD, etc.), end-user (hospitals, homecare, ambulatory centers), and technology type, while identifying unmet needs and growth opportunities.
The competitive landscape features key medical device companies focusing on expanding their HFOT portfolios, strategic collaborations, and R&D efforts aimed at enhancing product efficacy and patient compliance. As healthcare systems increasingly shift toward non-invasive and cost-effective respiratory care strategies, the global High Flow Oxygen Therapy Devices market is expected to see sustainable growth with broader adoption in both acute and chronic care environments.
Explore the latest trends and growth drivers in the High Flow Oxygen Therapy Devices Market-download your sample report now https://www.delveinsight.com/report-store/high-flow-oxygen-therapy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Key Takeaways from the High-Flow Oxygen Therapy Devices Market Report
• The global high-flow oxygen therapy devices market is projected to grow at a 2.31% CAGR from 2025 to 2032.
• As per DelveInsight estimates, North America is anticipated to dominate the global high-flow oxygen therapy devices market during the forecast period.
• Notable high flow oxygen therapy device companies such as Fisher & Paykel Healthcare, Masimo, Vapotherm, BMC Medical, ResMed, Allied Medical Limited, Hamilton Medical, Neotech Medical Systems Pvt. Ltd., Respircare, Ambulanc (Shenzhen) Tech. Co., Ltd., Intersurgical Ltd., Drägerwerk AG & Co. KGaA, MEKICS Co., Ltd., Peak Medical, Koninklijke Philips N.V., Hamilton Medical, GE Healthcare, Medtronic plc., Mindray, Nihon Kohden, Smiths Medical, and several others are currently operating in the high flow oxygen therapy devices market.
• In October 2023, the FDA granted 510(k) clearance to the Bonhawa High Flow Oxygen Therapy system for treating respiratory insufficiency.
• In March 2022, Fisher & Paykel Healthcare Corporation Limited announced that it had released the Airvo 3 high flow oxygen therapy system.
To read more about the latest highlights related to the high flow oxygen therapy devices market, get a snapshot of the key highlights entailed in the global high flow oxygen therapy devices market report here https://www.delveinsight.com/report-store/high-flow-oxygen-therapy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
High-Flow Oxygen Therapy Devices Overview
High-Flow Oxygen Therapy (HFOT) devices are advanced respiratory support systems designed to deliver a high flow of oxygen-enriched air to patients suffering from acute or chronic respiratory distress. Unlike conventional oxygen therapy, HFOT provides heated and humidified oxygen at flow rates up to 60 liters per minute through a nasal cannula, improving oxygenation and reducing the work of breathing.
These devices are particularly useful in managing conditions like chronic obstructive pulmonary disease (COPD), acute hypoxemic respiratory failure, bronchiolitis, pneumonia, and COVID-19. HFOT is increasingly favored in intensive care units (ICUs), emergency departments, and home care settings due to its ability to avoid the need for invasive ventilation while enhancing patient comfort.
The components of a typical HFOT system include an air-oxygen blender, an active humidifier, heated tubing, and a high-flow nasal cannula. Their clinical benefits, such as improved mucociliary clearance, better tolerance, and consistent oxygen delivery, make them a preferred choice in both pediatric and adult respiratory care.
With rising respiratory disease prevalence and the push toward non-invasive therapies, HFOT devices continue to gain importance as a frontline tool in modern respiratory care management.
High Flow Oxygen Therapy Devices Market Insights
North America is projected to dominate the global high-flow oxygen therapy devices market in 2024, driven by its advanced healthcare infrastructure, rapid adoption of non-invasive respiratory technologies, and a growing burden of chronic respiratory diseases like COPD, asthma, and sleep apnea. The surge in respiratory infections, including pneumonia and COVID-19, has further accelerated the demand for high-flow oxygen devices across hospitals, home care, and emergency settings.
According to 2024 data from the American Lung Association and the CDC, asthma affects 10.8% of females and 6.5% of males, while 4.6% of U.S. adults were diagnosed with COPD or related conditions in 2022. These illnesses often require long-term oxygen support, positioning high-flow oxygen therapy as a preferred solution due to its ability to deliver heated, humidified oxygen at controlled flow rates, enhancing oxygenation and reducing respiratory distress.
Technological advancements-such as AI and IoT integration-are enabling smart, personalized oxygen delivery, while innovations in materials have made devices more portable for home-based care. Additionally, frequent product launches and regulatory approvals are strengthening the market. For instance, in February 2021, Masimo launched the softFlow® 50 system in the U.S., offering consistent high-flow respiratory support via a soft nasal cannula.
These factors collectively reinforce North America's position as the leading market for high-flow oxygen therapy devices.
To know more about why North America is leading the market growth in the high flow oxygen therapy devices market, get a snapshot of the high flow oxygen therapy devices market outlook here https://www.delveinsight.com/report-store/high-flow-oxygen-therapy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
High Flow Oxygen Therapy Devices Market Dynamics
The global high-flow oxygen therapy (HFOT) devices market is expected to grow steadily through 2032, driven by the rising prevalence of chronic respiratory diseases. According to the Australian Institute of Health and Welfare (2022), around 8.5 million Australians (34%) had chronic respiratory conditions, while the Global Burden of Disease (2023) estimated that 1 in 20 people globally are affected. Additionally, the WHO (2024) reports that asthma impacts 262 million people worldwide, underscoring the growing need for effective oxygen delivery systems.
The increasing incidence of COPD, asthma exacerbations, and pollution-induced respiratory distress has propelled demand for HFOT, which delivers heated, humidified oxygen at high flow rates, improving oxygenation and reducing patient discomfort.
Home healthcare and telemedicine adoption are further expanding the market, as patients increasingly prefer personalized, non-invasive therapies. Advancements in remote monitoring, AI-driven oxygen adjustment, and wireless connectivity are enabling wider use of HFOT devices in home settings, cutting hospital admissions and improving outcomes.
Recent developments reinforce this trend: Telesair's Bonhawa system received CE Mark in August 2023, and in July 2024, Owens & Minor acquired Rotech Healthcare, one of the largest U.S. home medical equipment providers, for $1.36 billion, boosting access to home oxygen solutions.
Despite this growth, product recalls and stringent regulatory requirements remain potential challenges during the forecast period (2025-2032).
Get a sneak peek at the high flow oxygen therapy devices market dynamics @ https://www.delveinsight.com/report-store/high-flow-oxygen-therapy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Coverage: Global
Study Period: 2022 to 2032
High Flow Oxygen Therapy Devices Market CAGR: ~2.31%
Key High Flow Oxygen Therapy Devices Companies: Fisher & Paykel Healthcare, Masimo, Vapotherm, BMC Medical, ResMed, Allied Medical Limited, Hamilton Medical, Neotech Medical Systems Pvt. Ltd., Respircare, Ambulanc (Shenzhen) Tech. Co., Ltd., Intersurgical Ltd., Drägerwerk AG & Co. KGaA, MEKICS Co., Ltd., Peak Medical, Koninklijke Philips N.V., Hamilton Medical, GE Healthcare, Medtronic plc., Mindray, Nihon Kohden, Smiths Medical, and others.
High Flow Oxygen Therapy Devices Market Segmentation
Market Segmentation By Product Type: High Flow Nasal Cannulas, Masks and Tubing, Ventilators, Standalone High Flow Oxygen Therapy Devices, and others.
Market Segmentation By Modality: Portable and Stationary
Market Segmentation By Application: Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease (COPD), Heart Failure, and Others
Market Segmentation By End-User: Hospitals and Clinics, Home Care Settings, Ambulatory Surgical Centers, and others.
Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
Which MedTech key players in the high flow oxygen therapy devices market are set to emerge as the trendsetter, explore @ https://www.delveinsight.com/report-store/high-flow-oxygen-therapy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=jpr
Table of Contents
1. High Flow Oxygen Therapy Devices Market Report Introduction
2. High Flow Oxygen Therapy Devices Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. High Flow Oxygen Therapy Devices Market Key Factors Analysis
6. High Flow Oxygen Therapy Devices Market Porter's Five Forces Analysis
7. High Flow Oxygen Therapy Devices Market Layout
8. High Flow Oxygen Therapy Devices Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us
Contact Us:
Jatin Vimal
jvimal@delveinsight.com
+14699457679
Healthcare Consulting
https://www.delveinsight.com/consulting-services
About DelveInsight
DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.
Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global High Flow Oxygen Therapy Devices Market to Grow at a Steady Pace Through 2032, Driven by Rising Respiratory Disorders and ICU Admissions | DelveInsight here
News-ID: 4087294 • Views: …
More Releases from DelveInsight
Glaucoma - Pipeline Insight, 2025: Advancing Beyond IOP Control Toward Neuroprot …
Glaucoma, a leading cause of irreversible blindness worldwide, is traditionally managed through therapies that lower intraocular pressure (IOP). However, as understanding of the disease evolves, there is growing recognition of the need for neuroprotective strategies that address underlying optic nerve damage and retinal ganglion cell (RGC) loss.
DelveInsight's "Glaucoma - Pipeline Insight, 2025" analyzes over 50+ emerging therapies that go beyond conventional IOP-lowering agents. The pipeline includes novel mechanisms such as…
Gene Therapy Market to Grow at a CAGR of 19.25% Through 2032, Driven by Breakthr …
The global gene therapy market is on a strong upward trajectory, fueled by scientific advancements, growing approvals, and rising demand for personalized and curative treatments. With a projected CAGR of 19.25% through 2032, gene therapy is transforming the treatment paradigm for genetic disorders, rare diseases, cancers, and even select infectious and neurodegenerative conditions.
Gene therapies offer the potential for long-term or permanent cures by delivering, altering, or replacing faulty genes at…
Global Spinal Implants Market to Grow at a CAGR of 5.50% Through 2032, Fueled by …
The spinal implants market is steadily expanding, driven by the increasing prevalence of degenerative spinal conditions, spinal injuries, deformities, and age-related disorders such as osteoporosis. With rising demand for motion-preserving and minimally invasive solutions, the market is undergoing a significant transformation shaped by advanced material science and surgical techniques.
Spinal implants play a pivotal role in stabilizing the spine, correcting deformities, and promoting spinal fusion after trauma or disease. The market…
Myelofibrosis - Pipeline Insight, 2025: Novel Disease-Modifying Therapies Target …
Myelofibrosis, a rare and chronic myeloproliferative neoplasm, is characterized by bone marrow fibrosis, abnormal blood cell production, and splenomegaly. Historically treated with symptom-focused therapies, the treatment landscape for myelofibrosis is now undergoing a significant transformation as disease-modifying approaches gain traction.
DelveInsight's "Myelofibrosis - Pipeline Insight, 2025" highlights over 40+ active pipeline candidates targeting various pathogenic mechanisms, including JAK-STAT signaling, fibrosis pathways, anemia management, and the malignant stem cell clone. Prominent therapeutic…
More Releases for Flow
Peak Flow Meter Market: Digital Peak Flow Meter to Capture Significant Share
Peak flow meters are the portable devices used to measure the activity in lungs and to evaluate how well the lungs are able to expel the air. It is a lung monitoring device and is used to measure peak expiratory flow rate and forced expiratory volume.
According to the Fact.MR report, the patients, especially in developing regions, will continue to significantly prefer peak flow meters, due to the low prices of…
Flow Cytometry Market Size 2020-26, Agilent Technologies, Apogee Flow Systems
The latest study on the Global Flow Cytometry market report represents a deep appraisal of the international industry. The research report on the worldwide Flow Cytometry market 2020-2026 sheds light on qualitative as well as quantitative insights, historical Flow Cytometry industry status and authorized projection related to the Flow Cytometry market size. Each and every segment exhibited in this report are discovered through verifiable research methods and techniques. It also…
WA Kates Flow Controllers from Fluid Controls help maintain constant flow rates
When determining how best to maintain flow rate, always remember this rule of thumb; in order to maintain flow rate, the velocity of the fluid must be constant.
To achieve this, the potential head must also be constant via a large orifice. Alternatively, this function can be attained by ensuring that the flow rate which enters the orifice is equal to that which leaves it.
At first glance, this may seem like…
Flow Rate Liquid Flow Meters Market: Competitive Dynamics & Global Outlook 2023
New report published by Global Info Research which offers insights on the global Multivariable Vortex Flowmeters market.
Multivariable vortex flowmeters can measure flow rates of various fluids including liquid, gas and steam, over a wide range of temperatures from -200 to +400 °c.
Click to view the full report TOC, figure and tables：
https://www.globalinforesearch.com/global-multivariable-vortex-flowmeters-market_p87354.html
Global Multivariable Vortex Flowmeters Market: Forecast by Type / Application / Region
The Multivariable Vortex Flowmeters market is expected to witness…
Turbine Flow Meters Market (Omega, Mass Flow, Sika) Analysis & Forecast 2017-202 …
HTF MI published a new industry research that focuses on Turbine Flow Meters market and delivers in-depth market analysis and future prospects of Global Turbine Flow Meters market. The study covers significant data which makes the research document a handy resource for marketing managers, analysts, industry executives, consultants, sales and product managers, and other key people who are in need of ready-to-access and self-analyzed study along with graphs and tables…
Intrinsically Safe, Wireless Flow Totalizer from SignalFire Provides Field Displ …
SignalFire Wireless Telemetry introduces a new Intrinsically Safe Wireless Flow Totalizer that connects to industry-standard inductive turbine flow meters (such as the AW-Lake TW Turbine) to measure, locally display, wirelessly transmit and archive flow measurements. Data and diagnostics are available locally using the display as well as remotely from a SignalFire Gateway using Modbus standard protocol.
Enhancing new or existing turbine meters with wireless data management capabilities, the SignalFire…
